Mechanistically, ERβ phosphorylation and non-genomic signaling of S-equol in cytotoxic CD8+ effector T-cells (Teffs) boosted T-cell receptor activity and PD1 Ab-driven anti-tumor response. This evidence concerns the gene CD8A and neoplasm.